{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:14:26Z","timestamp":1784988866416,"version":"3.55.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.semarthrit.2011.06.003","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T22:16:36Z","timestamp":1314310596000},"page":"335-345.e6","source":"Crossref","is-referenced-by-count":56,"title":["A Systematic Review and Mixed Treatment Comparison of the Efficacy of Pharmacological Treatments for Fibromyalgia"],"prefix":"10.1016","volume":"41","author":[{"given":"Ernest","family":"Choy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahava L.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gylee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Dakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semarthrit.2011.06.003_bib1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11916-001-0021-2","article-title":"Classification, epidemiology, and natural history of fibromyalgia","volume":"5","author":"White","year":"2001","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2011.06.003_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib3","first-page":"6","article-title":"Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment","volume":"75","author":"Mease","year":"2005","journal-title":"J Rheumatol Suppl"},{"issue":"1","key":"10.1016\/j.semarthrit.2011.06.003_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pec.2008.06.005","article-title":"Patient perspectives on the impact of fibromyalgia","volume":"73","author":"Arnold","year":"2008","journal-title":"Patient Educ Couns"},{"issue":"1","key":"10.1016\/j.semarthrit.2011.06.003_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1742-1241.2007.01638.x","article-title":"The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12","volume":"62","author":"Hoffman","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1874312900903010025","article-title":"Efficacy of acupuncture for the treatment of fibromyalgia: systematic review and meta-analysis of randomized trials","volume":"3","author":"Martin-Sanchez","year":"2009","journal-title":"Open Rheumatol J"},{"issue":"9","key":"10.1016\/j.semarthrit.2011.06.003_bib7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/art.24000","article-title":"A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome","volume":"59","author":"Uceyler","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.semarthrit.2011.06.003_bib8","first-page":"1418","article-title":"Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome\u2014a preliminary study","volume":"23","author":"Hrycaj","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib9","first-page":"335","article-title":"Fibromyalgia: effects of temazepam, amitriptyline and placebo on pain and sleep","volume":"18","author":"Hench","year":"1989","journal-title":"Sleep Res"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib10","first-page":"140","article-title":"A randomized trial of cyclobenzaprine for the treatment of fibromyalgia","volume":"19","author":"Quimby","year":"1989","journal-title":"J Rheumatol Suppl"},{"issue":"3 Suppl 5","key":"10.1016\/j.semarthrit.2011.06.003_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S109285290002678X","article-title":"Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia","volume":"13","author":"Staud","year":"2008","journal-title":"CNS Spectr"},{"issue":"1\u20132","key":"10.1016\/j.semarthrit.2011.06.003_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","article-title":"Treatment of fibromyalgia syndrome with gabapentin and pregabalin\u2014A meta-analysis of randomized controlled trials","volume":"145","author":"Hauser","year":"2009","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.semarthrit.2011.06.003_bib13","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/rheumatology\/ken317","article-title":"Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy","volume":"47","author":"Nishishinya","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.semarthrit.2011.06.003_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpain.2010.01.002","article-title":"Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome","volume":"11","author":"Hauser","year":"2010","journal-title":"J Pain"},{"issue":"6","key":"10.1016\/j.semarthrit.2011.06.003_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2710.2009.01144.x","article-title":"Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis","volume":"35","author":"Tzellos","year":"2010","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.06.003_bib16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/keq354","article-title":"Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"50","author":"Hauser","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2011.06.003_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.2007.071522","article-title":"EULAR evidence-based recommendations for the management of fibromyalgia syndrome","volume":"67","author":"Carville","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"10.1016\/j.semarthrit.2011.06.003_bib18","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.292.19.2388","article-title":"Management of fibromyalgia syndrome","volume":"292","author":"Goldenberg","year":"2004","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.semarthrit.2011.06.003_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00393-008-0404-4","article-title":"[Definition, classification and diagnosis of fibromyalgia syndrome]","volume":"67","author":"Eich","year":"2008","journal-title":"Z Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2011.06.003_bib20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3899\/jrheum.080734","article-title":"The efficacy and safety of milnacipran for treatment of fibromyalgia","volume":"36","author":"Mease","year":"2009","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.06.003_bib21","first-page":"502","article-title":"A randomized double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia","volume":"35","author":"Mease","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib22","series-title":"A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia","author":"Chappell","year":"2008"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.06.003_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00002508-200209000-00008","article-title":"Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia","volume":"18","author":"Sim","year":"2002","journal-title":"Clin J Pain"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.06.003_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11916-005-0003-x","article-title":"Pharmacologic treatment of fibromyalgia","volume":"9","author":"Baker","year":"2005","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2011.06.003_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11926-000-0048-0","article-title":"The treatment of fibromyalgia: a review of clinical trials","volume":"2","author":"Crofford","year":"2000","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2011.06.003_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02908299","article-title":"A meta-analysis of fibromyalgia treatment interventions","volume":"21","author":"Rossy","year":"1999","journal-title":"Ann Behav Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2011.06.003_bib27","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.3899\/jrheum.080077","article-title":"Systematic review of discriminating power of outcome measures used in clinical trials of fibromyalgia","volume":"35","author":"Carville","year":"2008","journal-title":"J Rheumatol"},{"issue":"20","key":"10.1016\/j.semarthrit.2011.06.003_bib28","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"issue":"7521","key":"10.1016\/j.semarthrit.2011.06.003_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.semarthrit.2011.06.003_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1745-6215-8-38","article-title":"OMERACT: An international initiative to improve outcome measurement in rheumatology","volume":"8","author":"Tugwell","year":"2007","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.06.003_bib32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1524-4733.2008.00347.x","article-title":"Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons","volume":"11","author":"Jansen","year":"2008","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.semarthrit.2011.06.003_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-200624010-00001","article-title":"Bayesian methods for evidence synthesis in cost-effectiveness analysis","volume":"24","author":"Ades","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10.1016\/j.semarthrit.2011.06.003_bib37","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archinte.166.12.1269","article-title":"Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation","volume":"166","author":"Cooper","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.06.003_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J094v06n02_02","article-title":"A pilot randomised placebo-controlled study of pirlindole in the treatment of primary fibromyalgia","volume":"6","author":"Ginsberg","year":"1998","journal-title":"J Musculoskeletal Pain"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.06.003_bib40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.amjmed.2006.06.006","article-title":"A randomized, controlled, trial of controlled release paroxetine in fibromyalgia","volume":"120","author":"Patkar","year":"2007","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2011.06.003_bib41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0011-393X(99)90008-5","article-title":"Efficacy and tolerability of paroxetine in patients with fibromyalgia syndrome: A single-blind study","volume":"60","author":"Giordano","year":"1999","journal-title":"Curr Therapeut Res Clin Exp"},{"issue":"1","key":"10.1016\/j.semarthrit.2011.06.003_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/eujp.1999.0148","article-title":"Citalopram in patients with fibromyalgia\u2014a randomized, double-blind, placebo-controlled study","volume":"4","author":"Anderberg","year":"2000","journal-title":"Eur J Pain"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.06.003_bib43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0304-3959(94)00218-4","article-title":"A randomized controlled trial of citalopram in the treatment of fibromyalgia","volume":"61","author":"Norregaard","year":"1995","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.06.003_bib44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","article-title":"Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial","volume":"136","author":"Russell","year":"2008","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.semarthrit.2011.06.003_bib45","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/art.20485","article-title":"A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder","volume":"50","author":"Arnold","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1-3","key":"10.1016\/j.semarthrit.2011.06.003_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.semarthrit.2011.06.003_bib47","first-page":"1975","article-title":"Efficacy of milnacipran in patients with fibromyalgia","volume":"32","author":"Gendreau","year":"2005","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2011.06.003_bib48","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.clinthera.2008.11.009","article-title":"Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial","volume":"30","author":"Clauw","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00124743-200010000-00003","article-title":"Efficacy of tramadol in treatment of pain in fibromyalgia","volume":"6","author":"Russell","year":"2000","journal-title":"J Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2011.06.003_bib50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","article-title":"A 14-week randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia","volume":"9","author":"Arnold","year":"2008","journal-title":"J Pain"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.06.003_bib51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pain.2008.02.027","article-title":"Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin","volume":"136","author":"Crofford","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.semarthrit.2011.06.003_bib52","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib53","series-title":"Pregabalin for management of fibromyalgia (FM): a 14-week randomized, double-blind, placebo-controlled, monotherapy trial (Study A0081100)","author":"Pauer","year":"2008"},{"issue":"6","key":"10.1016\/j.semarthrit.2011.06.003_bib54","first-page":"697","article-title":"A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia","volume":"19","author":"Heymann","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.06.003_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1300\/J094v04n03_05","article-title":"A randomized placebo-controlled trial of sustained-release amitriptyline in primary fibromyalgia","volume":"4","author":"Ginsberg","year":"1996","journal-title":"J Musculoskeletal Pain"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.06.003_bib56","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/art.1780340507","article-title":"Treatment of primary fibrositis\/fibromyalgia syndrome with ibuprofen and alprazolam","volume":"34","author":"Russell","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"2-3","key":"10.1016\/j.semarthrit.2011.06.003_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3959(95)00199-9","article-title":"Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial","volume":"65","author":"Quijada Carrera","year":"1996","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.semarthrit.2011.06.003_bib58","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"issue":"19","key":"10.1016\/j.semarthrit.2011.06.003_bib59","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/sim.1566","article-title":"A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence","volume":"22","author":"Ades","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1745-6215-10-86","article-title":"Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison","volume":"10","author":"O'Regan","year":"2009","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.semarthrit.2011.06.003_bib61","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1002\/art.11272","article-title":"Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors","volume":"48","author":"Giesecke","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.semarthrit.2011.06.003_bib62","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.21191","article-title":"A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications","volume":"52","author":"Holman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib63","series-title":"Effects of sodium oxybate on sleep physiology and sleep-related symptoms in fibromyalgia","author":"Moldofsky","year":"2008"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.06.003_bib64","first-page":"1070","article-title":"The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia","volume":"30","author":"Scharf","year":"2003","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.06.003_bib65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9343(01)01089-0","article-title":"A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia","volume":"112","author":"Arnold","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib66","series-title":"Milnacipran for the treatment of fibromyalgia syndrome: a European multicenter, randomized, double-blind, placebo-controlled trial","author":"Branco","year":"2008"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib67","series-title":"The effect of milnacipran on pain modulatory systems in fibromyalgia: an FMRI analysis","author":"Gracely","year":"2008"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.06.003_bib68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/AJP.0b013e31819be587","article-title":"A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia","volume":"25","author":"Chappell","year":"2009","journal-title":"Clin J Pain"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib69","series-title":"A double-blind trial comparing mirtazapine with placebo in the treatment of fibromyalgia patients with major depressive disorder (621-P227)","author":"Erhan","year":"2005"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib70","series-title":"The efficacy of venlafaxine in treatment of fibromyalgia","author":"Borman","year":"2004"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib71","series-title":"Milnacipran efficacy in the treatment of fibromyalgia syndrome: a 15-week, randomised, double-blind, placebo-controlled trial","author":"Clauw","year":"2007"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib72","series-title":"One-year durability of response to milnacipran treatment for fibromyalgia","author":"Goldenberg","year":"2007"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib73","series-title":"The efficacy and safety of milnacipran in the treatment of fibromyalgia","author":"Clauw","year":"2007"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib74","series-title":"Duloxetine 60-120 mg versus placebo in the treatment of fibromyalgia syndrome","author":"Chappell","year":"2007"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IJGM.S3979","article-title":"A six-month, double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia","volume":"1","author":"Chappell","year":"2008","journal-title":"Int J Gen Med"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2011.06.003_bib76","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/hup.622","article-title":"A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia","volume":"19","author":"Vitton","year":"2004","journal-title":"Human Psychopharmacol"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib77","series-title":"Low dose of tramadol in the treatment of fibromyalgia syndrome: a controlled clinical trial versus placebo","author":"Gur","year":"2006"},{"issue":"7","key":"10.1016\/j.semarthrit.2011.06.003_bib78","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","article-title":"Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study","volume":"114","author":"Bennett","year":"2003","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2011.06.003_bib79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/art.21319","article-title":"Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol\/acetaminophen","volume":"53","author":"Bennett","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib80","series-title":"A randomized, double-blind, placebo-controlled trial of levetiracetam for treatment of pain and disturbed sleep associated with fibromyalgia","author":"Rowbotham","year":"2007"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib81","series-title":"Efficacy of pregablin monotherapy for relief of pain associated with fibromyalgia: time course and durability of pain results of a 14-week, double-blind, placebo-controlled trial","author":"Duan","year":"2007"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib82","series-title":"Pregabalin therapy for durability of meaningful relief of fibromyalgia","author":"Simpson","year":"2007"},{"issue":"4","key":"10.1016\/j.semarthrit.2011.06.003_bib83","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.22457","article-title":"Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"56","author":"Arnold","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2011.06.003_bib84","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"J Pain"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.06.003_bib85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1163\/156856902320761423","article-title":"Comparison of the effects of amitriptyline and paroxetine in the treatment of fibromyalgia syndrome","volume":"14","author":"Capaci","year":"2002","journal-title":"Pain Clin"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib86","doi-asserted-by":"crossref","first-page":"535","DOI":"10.55730\/1300-0144.5001","article-title":"Comparison of paroxetine, amitriptyline in the treatment of fibromyalgia","volume":"27","author":"Ataoglu","year":"1997","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.semarthrit.2011.06.003_bib87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-4613-0381-7_58","article-title":"Fibromyalgia and migraine, two faces of the same mechanism","volume":"398","author":"Nicolodi","year":"1996","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.semarthrit.2011.06.003_bib88","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/rheumatology\/37.12.1279","article-title":"A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder","volume":"37","author":"Hannonen","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2011.06.003_bib89","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00296-005-0079-y","article-title":"Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns","volume":"26","author":"Ozgocmen","year":"2006","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.06.003_bib90","first-page":"1124","article-title":"Fluvoxamine therapy for fibromyalgia","volume":"30","author":"Nishikai","year":"2003","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2011.06.003_bib91","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/art.1780391111","article-title":"A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia","volume":"39","author":"Goldenberg","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2011.06.003_bib92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.1780370106","article-title":"Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: A randomized, double-blind clinical trial","volume":"37","author":"Carette","year":"1994","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721100179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721100179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:40:01Z","timestamp":1686271201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901721100179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S004901721100179X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2011.06.003","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}